Podlipec Rok, Mur Jaka, Petelin Jaka, Štrancar Janez, Petkovšek Rok
Laboratory of Biophysics, Condensed Matter Physics Department, Jožef Stefan Institute, Jamova cesta 39, Ljubljana, Slovenia.
Helmholtz-Zentrum Dresden-Rossendorf e.V., Ion Beam Center, Bautzner Landstraße 400, Dresden 01328, Germany.
Biomed Opt Express. 2021 Aug 30;12(9):5881-5893. doi: 10.1364/BOE.428467. eCollection 2021 Sep 1.
Tissue diseases and related disorders need to be first recognized using diagnostic methods and then later treated by therapeutic methods-a joint procedure called theranostics. One of the main challenges in the field of retinal therapies remains in the success of the treatment, typically improving the local metabolism, by sparing the surrounding tissue and with the immediate information of the laser effect. In our study, we present a concept for real-time controlled tissue theranostics on a proof-of-concept study capable of using a single tunable ps laser source (in terms of irradiance, fluence, and repetition rate), done on ex-vivo human retinal pigment epithelium. We have found autofluorescence intensity and lifetime imaging diagnostics very promising for the recognition and quantification of laser effects ranging from selective non-destructive molecular tissue modification to complete tissue ablation. The main novelty of our work presents the developed algorithm for optimized theranostics based on the model function used to quantify laser-induced tissue changes through the diagnostics descriptors, fluorescence lifetime and fluorescence intensity parameters. This approach, together with the operation of the single adaptable laser source, can serve as a new theranostics method in personalized medicine in the future not only limited to treat retinal diseases.
组织疾病及相关病症首先需要通过诊断方法来识别,随后采用治疗方法进行治疗——这一联合过程称为治疗诊断学。视网膜治疗领域的主要挑战之一仍然在于治疗的成功率,具体而言,即通过保护周围组织并即时获取激光效应信息来改善局部新陈代谢。在我们的研究中,我们在一项概念验证研究中提出了一种用于实时控制组织治疗诊断学的概念,该研究能够使用单一可调谐皮秒激光源(在辐照度、能量密度和重复频率方面),并在离体人视网膜色素上皮上进行。我们发现,自荧光强度和寿命成像诊断对于识别和量化从选择性非破坏性分子组织修饰到完全组织消融的激光效应非常有前景。我们工作的主要新颖之处在于基于模型函数开发了一种用于优化治疗诊断学的算法,该模型函数用于通过诊断描述符、荧光寿命和荧光强度参数来量化激光诱导的组织变化。这种方法,连同单一可适配激光源的操作,未来不仅可用于治疗视网膜疾病,还能作为个性化医学中的一种新的治疗诊断方法。